A Study on Financial Performance of Pharmaceutical Company - International Journal of Trend in Scientific Research and Development

IJTSRD is a leading Open Access, Peer-Reviewed International Journal which provides rapid publication of your research articles and aims to promote the theory and practice along with knowledge sharing between researchers, developers, engineers, students, and practitioners working in and around the world in many areas. For any further information, feel free to write us on editor.ijtsrd@gmail.com

Thursday 5 April 2018

A Study on Financial Performance of Pharmaceutical Company


Indian Pharmaceutical division is very disjointed with more than 20,000 registered units. The pharmaceutical and organic industry in India is a very fragmented bazaar with simple value rivalry and administration price regulator. There are almost 250 great units and around 8000 small-scale elements, which method the essential of the Pharmaceutical Manufacturing in India (counting 5 central public sector units) Perceiving fast, the worldwide pharma marketplace stands valued to extra than dual to $1.3 billion by the year 2020.


The Indian Pharmaceutical Developed is developing extremely individually year. Hence a sweat has been over to study the effectiveness location of the industry with the profit of cruel, standard deviation, co-efficient of variation, multiple regression, and study of change. The growth in profitability will not only yield greater effectiveness then also advance financial performance in future. 

by Dr. S. Saravanan | R. Prabhu "A Study on Financial Performance of Pharmaceutical Company" 

Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-2 | Issue-3 , April 2018, 

URL: http://www.ijtsrd.com/papers/ijtsrd11425.pdf

Direct Link - http://www.ijtsrd.com/management/accounting-and-finance/11425/a-study-on-financial-performance-of-pharmaceutical-company/dr-s-saravanan

paper publication, best international journal, management journal

No comments:

Post a Comment

Ad